Department of Cardiology, Scripps Mercy Hospital San Diego, 4077 Fifth Avenue, San Diego, CA 92103, USA.
Department of Internal Medicine, Wake Forest School of Medicine, 300 Medical Center Boulevard, Winston-Salem, NC 27157, USA; Department of Anesthesiology, Wake Forest School of Medicine, 300 Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Interv Cardiol Clin. 2022 Jul;11(3):325-338. doi: 10.1016/j.iccl.2022.03.005. Epub 2022 Mar 28.
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious pathogen resulting in the 2019 coronavirus disease (COVID-19) pandemic with direct impact on cardiac catheterization laboratory (CCL) operations. Initially, major challenges in limiting the spread of aerosolized pathogens existed until protocols were implemented to limit infectivity to staff and patients. COVID-19 increases the risk of myocardial infarctions and cardiogenic shock requiring acute management in the CCL. In this review, we specify best practices in the CCL for the management of infected patients in the preprocedure, intraprocedure, and postprocedure environments harmonizing available evidence, recommendations from international heart associations, and consensus opinion.
严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）是一种高度传染性病原体，导致 2019 年冠状病毒病（COVID-19）大流行，对心脏导管室（CCL）的运行产生直接影响。最初，在实施限制传染性给工作人员和患者的方案之前，存在着限制气溶胶化病原体传播的主要挑战。COVID-19 增加了心肌梗死和心源性休克的风险，需要在 CCL 中进行急性治疗。在这篇综述中，我们在 CCL 中为感染患者制定了最佳实践，包括术前、术中和术后环境，协调了现有证据、国际心脏协会的建议和共识意见。
